447 related articles for article (PubMed ID: 25429073)
1. Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.
Dugan J; Griffiths E; Snow P; Rosenzweig H; Lee E; Brown B; Carr DW; Rose C; Rosenbaum J; Davey MP
J Immunol; 2015 Jan; 194(1):349-57. PubMed ID: 25429073
[TBL] [Abstract][Full Text] [Related]
2. Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
Mao L; Dhar A; Meng G; Fuss I; Montgomery-Recht K; Yang Z; Xu Q; Kitani A; Strober W
Front Immunol; 2022; 13():988862. PubMed ID: 36189261
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
Yao Q
Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
[TBL] [Abstract][Full Text] [Related]
4. A Novel NOD2-associated Mutation and Variant Blau Syndrome: Phenotype and Molecular Analysis.
Ebrahimiadib N; Samra KA; Domina AM; Stiles ER; Ewer R; Bocian CP; Foster CS
Ocul Immunol Inflamm; 2018; 26(1):57-64. PubMed ID: 27419275
[TBL] [Abstract][Full Text] [Related]
5. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
[TBL] [Abstract][Full Text] [Related]
6. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
[TBL] [Abstract][Full Text] [Related]
7. Blau Syndrome: NOD2-related systemic autoinflammatory granulomatosis.
Takada S; Saito MK; Kambe N
G Ital Dermatol Venereol; 2020 Oct; 155(5):537-541. PubMed ID: 32618442
[TBL] [Abstract][Full Text] [Related]
8. Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages.
Hedl M; Abraham C
J Biol Chem; 2011 Jul; 286(30):26440-9. PubMed ID: 21659536
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis.
Zhang S; Zhang S; Hu L; Zhai L; Xue R; Ye J; Chen L; Cheng G; Mruk J; Kunapuli SP; Ding Z
Circulation; 2015 Mar; 131(13):1160-70. PubMed ID: 25825396
[TBL] [Abstract][Full Text] [Related]
10. A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κB signaling pathways.
Warner N; Burberry A; Franchi L; Kim YG; McDonald C; Sartor MA; Núñez G
Sci Signal; 2013 Jan; 6(258):rs3. PubMed ID: 23322906
[TBL] [Abstract][Full Text] [Related]
11. E3 Ubiquitin ligase ZNRF4 negatively regulates NOD2 signalling and induces tolerance to MDP.
Bist P; Cheong WS; Ng A; Dikshit N; Kim BH; Pulloor NK; Khameneh HJ; Hedl M; Shenoy AR; Balamuralidhar V; Malik NBA; Hong M; Neutzner A; Chin KC; Kobayashi KS; Bertoletti A; Mortellaro A; Abraham C; MacMicking JD; Xavier RJ; Sukumaran B
Nat Commun; 2017 Jun; 8():15865. PubMed ID: 28656966
[TBL] [Abstract][Full Text] [Related]
12. Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP.
Mo J; Boyle JP; Howard CB; Monie TP; Davis BK; Duncan JA
J Biol Chem; 2012 Jun; 287(27):23057-67. PubMed ID: 22549783
[TBL] [Abstract][Full Text] [Related]
13. Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.
Prakhar P; Holla S; Ghorpade DS; Gilleron M; Puzo G; Udupa V; Balaji KN
J Biol Chem; 2015 Oct; 290(44):26576-86. PubMed ID: 26391398
[TBL] [Abstract][Full Text] [Related]
14. Brief Report: First Identification of Intrafamilial Recurrence of Blau Syndrome due to Gonosomal NOD2 Mosaicism.
Mensa-Vilaro A; Cham WT; Tang SP; Lim SC; González-Roca E; Ruiz-Ortiz E; Ariffin R; Yagüe J; Aróstegui JI
Arthritis Rheumatol; 2016 Apr; 68(4):1039-44. PubMed ID: 26606664
[TBL] [Abstract][Full Text] [Related]
15. TAK1 is a central mediator of NOD2 signaling in epidermal cells.
Kim JY; Omori E; Matsumoto K; Núñez G; Ninomiya-Tsuji J
J Biol Chem; 2008 Jan; 283(1):137-144. PubMed ID: 17965022
[TBL] [Abstract][Full Text] [Related]
16. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.
Okafuji I; Nishikomori R; Kanazawa N; Kambe N; Fujisawa A; Yamazaki S; Saito M; Yoshioka T; Kawai T; Sakai H; Tanizaki H; Heike T; Miyachi Y; Nakahata T
Arthritis Rheum; 2009 Jan; 60(1):242-50. PubMed ID: 19116920
[TBL] [Abstract][Full Text] [Related]
17. NOD2, the gene responsible for familial granulomatous uveitis, in a mouse model of uveitis.
Rosenzweig HL; Martin TM; Jann MM; Planck SR; Davey MP; Kobayashi K; Flavell RA; Rosenbaum JT
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1518-24. PubMed ID: 18385071
[TBL] [Abstract][Full Text] [Related]
18. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
[TBL] [Abstract][Full Text] [Related]
19. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo and in vitro production of pro-inflammatory cytokines in Blau syndrome.
Galozzi P; Negm O; Greco E; Alkhattabi N; Gava A; Sfriso P; Fairclough L; Todd I; Tighe P; Punzi L
Reumatismo; 2015 Mar; 66(4):277-84. PubMed ID: 25829188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
